SureTrader SureTrader SureTrader
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 1/21/2017 3:36:55 AM - Followers: 1317 - Board type: Free - Posts Today: 1

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#208244  Sticky Note BMY/Ono collect $625M+royalties from MRK in global PD-1-patent settlement: DewDiligence 01/20/17 04:26:45 PM
#208239  Sticky Note BMY’s tight-lipped pass on accelerated lung cancer drug Titan V 01/20/17 11:27:06 AM
#208233  Sticky Note ARIA: The merger documents are out. The initial ghmm 01/20/17 07:41:58 AM
#208231  Sticky Note The cancer reproducibility project is trying to reproduce iwfal 01/20/17 07:01:13 AM
#208169  Sticky Note TEVA—With the stock cut in half already, it DewDiligence 01/18/17 04:53:36 PM
#208121  Sticky Note FDA rejects ABBV’s CP on indication extrapolation for DewDiligence 01/18/17 11:16:25 AM
#208253   FGEN poster at ASCO GI from twitter. Note Jonathan Robinson 01/21/17 03:36:54 AM
#208252   On CALA's website, they note they've licensed things mcbio 01/20/17 10:42:18 PM
#208251   It didn't take long for BMY stock to Titan V 01/20/17 10:28:48 PM
#208250   Next Alzheimer's 10X MEGA PLAY...just google Bryostatin.R/S.Float Locked!..LINK bUrRpPPP! 01/20/17 09:04:22 PM
#208249   Addendum: BMY stands to benefit more than most DewDiligence 01/20/17 06:53:57 PM
#208248   Mars Inc. makes a lot more than chocolate; DewDiligence 01/20/17 06:47:57 PM
#208247   CALA truly licensed from the Mars corporation that xavierprivas 01/20/17 06:34:18 PM
#208246   RE: Arginase / IDO / TDO poorgradstudent 01/20/17 05:35:25 PM
#208245   How a biotech startup rose, and then fell Titan V 01/20/17 05:27:06 PM
#208244   BMY/Ono collect $625M+royalties from MRK in global PD-1-patent settlement: DewDiligence 01/20/17 04:26:45 PM
#208243   INCY/MRK/IOmet/CALA - This MRK purchase is interesting and mcbio 01/20/17 03:40:43 PM
#208242   Added BMY today at $49.36 (eom). DewDiligence 01/20/17 03:30:07 PM
#208241   If I recall correctly, prices had recently gone Jonathan Robinson 01/20/17 01:54:04 PM
#208240   Merck CEO sees Keytruda in pole position in Titan V 01/20/17 11:33:56 AM
#208239   BMY’s tight-lipped pass on accelerated lung cancer drug Titan V 01/20/17 11:27:06 AM
#208238   Frightening information from the CDC on why antibiotics vinmantoo 01/20/17 11:25:47 AM
#208237   OMER (prior P2 aHUS data) - One issue mcbio 01/20/17 11:13:20 AM
#208236   My only comment on the paper is that dewophile 01/20/17 10:02:27 AM
#208235   According to a landmark "Antibiotic Resistance Threat Report" biocqr 01/20/17 09:37:38 AM
#208234   Frightening information from the CDC on why antibiotics biotech_researcher 01/20/17 08:05:16 AM
#208233   ARIA: The merger documents are out. The initial ghmm 01/20/17 07:41:58 AM
#208232   Vyvanse life cycle management?? mr_o 01/20/17 07:33:27 AM
#208231   The cancer reproducibility project is trying to reproduce iwfal 01/20/17 07:01:13 AM
#208230   MYOV. Anyone in this one or following the lgonber 01/20/17 05:17:37 AM
#208229   SGYP. the approval is pretty clean IMO, I lgonber 01/20/17 05:15:41 AM
#208228   Francis Collins staying put at NIH—at least for now: DewDiligence 01/19/17 07:48:48 PM
#208227   SGYP - I'm a little surprised the FDA iandy 01/19/17 07:26:59 PM
#208226   BMY won't pursue FDA accelerated approval for Opdivo/Yervoy DewDiligence 01/19/17 07:22:30 PM
#208225   IBM Voice: Five Technologies That Will Help To biotech_researcher 01/19/17 07:12:19 PM
#208224   I agree. Comparing this event in 2000 as Titan V 01/19/17 05:20:27 PM
#208223   among the issues Wasserman points out are that dewophile 01/19/17 04:52:18 PM
#208222   FDA approves Trulance (plecanatide)—but SGYP -10%/AH on label concerns: DewDiligence 01/19/17 04:14:58 PM
#208221   SHPG resubmits NDA for long-acting amphetamine after 10-year(!) wait: DewDiligence 01/19/17 04:07:13 PM
#208220   ZYNE sells 3.24M* shares @$18.00—a 20% discount to DewDiligence 01/19/17 03:58:36 PM
#208219   That’s a bad article, IMO. I don’t think DewDiligence 01/19/17 03:45:05 PM
#208218   The Last Time This Happened, Biotech Stocks Plunged Titan V 01/19/17 03:36:07 PM
#208217   Re: AQB valuation DewDiligence 01/19/17 03:19:05 PM
#208216   PD-L1 as a Biomarker Predictive of Response to Titan V 01/19/17 02:41:50 PM
#208215   BMY—Do you anticipate approval in the US based DewDiligence 01/19/17 02:31:52 PM
#208214   Irv Wasserman has a fairly aggressive critique of jb_118 01/19/17 02:31:29 PM
#208213   CD47/SIRP: Are you suggesting there are concerns now about poorgradstudent 01/19/17 02:16:00 PM
#208212   AQB Have you done any valuation work on this? WorstLuck 01/19/17 02:03:35 PM
#208211   for tril it's neither here nor there. the linhdtu 01/19/17 01:57:08 PM
#208210   BMY With these phase-3 data, Opdivo label expansion JohnWayne 01/19/17 01:48:14 PM
#208209   The cancer reproducibility project is trying to reproduce mcbio 01/19/17 01:33:40 PM
#208208   what do you make of this? tril? ronpopeil 01/19/17 01:18:31 PM
#208207   Reproducibility / SIRP-CD47: poorgradstudent 01/19/17 01:12:32 PM
#208206   Is anyone still in TRIL? The price action ronpopeil 01/19/17 12:56:35 PM
#208204   AQB is now trading on Nasdaq: DewDiligence 01/19/17 11:58:41 AM
#208203   Re: Biotech reverse mergers DewDiligence 01/19/17 11:43:26 AM
PostSubject